Elsevier

Biomaterials

Volume 30, Issue 30, October 2009, Pages 5988-5998
Biomaterials

Cholesterol-mediated anchoring of enzyme-loaded liposomes within disulfide-stabilized polymer carrier capsules

https://doi.org/10.1016/j.biomaterials.2009.07.040Get rights and content

Abstract

Polymer capsules containing multiple liposomes, termed capsosomes, are a promising new concept toward the design of artificial cells. Herein, we report on the fundamental aspects underpinning the assembly of capsosomes. A stable and high loading of intact liposomal cargo into a polymer film was achieved by non-covalently sandwiching the liposomes between a tailor-made cholesterol-modified poly(l-lysine) (PLLc) precursor layer and a poly(methacrylic acid)-co-(cholesteryl methacrylate) (PMAc) capping layer. The film assembly, optimized on planar surfaces, was successfully transferred onto colloidal substrates, and a polymer membrane was subsequently assembled by the alternating adsorption of poly(N-vinyl pyrrolidone) (PVP) and thiol-modified poly(methacrylic acid) (PMASH) onto the pre-adsorbed layer of liposomes. Upon removal of the silica template, stable capsosomes encapsulating the enzyme luciferase or β-lactamase within their liposomal sub-compartments were obtained at both assembly (pH 4) and physiological conditions (pH 7.4). Excellent retention of the liposomes and the enzymatic cargo within the polymer carrier capsules was observed for up to 14 days. These engineered capsosomes are particularly attractive as autonomous microreactors, which can be utilized to repetitively add smaller reactants to cause successive distinct reactions within the capsosomes and simultaneously release the products to the surrounding environment, bringing these systems one step closer toward constructing artificial cells.

Introduction

Biological cells, which separate their interior from the exterior media by a lipid bilayer, operate by performing multiple enzymatic cascade reactions within predefined sub-compartments, the cell organelles. The lipid barrier is equipped with various biomolecules, including ion channels and transmembrane proteins, which serve as specific gates. Artificial cells [1], [2], on the other hand, do not require the complex multifunctionality of their biological counterparts, but rather can be more simply designed to perform a specific activity. However, certain prerequisites have to be fulfilled. Among them is the need of a micron-sized vessel with specific permeability that provides the structural scaffold and the encapsulated machinery that enables confined specific reactions to be conducted. Polymer [3], [4], [5] or lipid [6], [7] vesicles and polymer capsules [8], [9], [10], [11], [12], [13] are suitable platforms that are being explored as microreactors to conduct encapsulated reactions and as advanced therapeutic delivery vehicles.

Recently, we reported the construction of a new class of colloidal carriers/microreactors, termed capsosomes [14]. These are obtained by incorporating intact liposomes into polymer capsules, assembled by the layer-by-layer (LbL) technique [15], [16]. The first generation of capsosomes we reported consist of intact, unsaturated, zwitterionic 50 nm liposomes incorporated in a non-biodegradable polyelectrolyte film assembled from poly(styrene sulfonate) (PSS) and poly(allylamine hydrochloride) (PAH) [14]. We confirmed the functionality of the capsosomes by performing a triggered quantitative enzymatic reaction using β-lactamase encapsulated within the liposomal sub-compartments [17]. These capsosomes are of interest because the polymer capsule provides a structural scaffold with controllable permeability and the liposomes divide the interior into sub-compartments, thus potentially allowing parallel encapsulated enzymatic cascade reactions within confined systems. The liposomes are well-suited to encapsulate small hydrophobic and hydrophilic drugs or fragile biomolecules. Furthermore, these loaded liposomes can be incorporated in the polymer film at different regions, giving access to multi-strata films that are expected to be useful for the co-administration of complementary drugs.

In the current study, we examine two main fundamental aspects regarding capsosome assembly and performance that strongly affect their functionality: (i) the loading efficiency and stability of the liposomal cargo into the polymer film; and (ii) the structural properties of the capsosomes containing enzyme-loaded liposomes. To optimize the loading of intact liposomes into polymer multilayer films, we introduce a non-covalent linkage concept for liposomes based on cholesterol-functionalized polymers. Further, the choice of the building blocks of the polymer carrier capsules governs the structural properties, including the long-term stability of the capsosomes, and thus the encapsulated species. PSS and PAH, for instance, provide a non-degradable carrier capsule that is attractive if repetitive function over an extended period of time is required. On the other hand, (bio)degradable polymer membranes enable the body to deconstruct the carrier vehicles into their building blocks after their task is fulfilled. Among a variety of polymer systems that are suitable for the assembly of (bio)degradable membranes [18], [19], [20], [21], [22], poly(N-vinyl pyrrolidone) (PVP) and thiol-modified poly(methacrylic acid) (PMASH) were chosen. Cross-linking the thiols of the PMASH and the release of PVP at physiological conditions yield colloidally stable, (bio)degradable, single-component PMA capsules [19]. We have demonstrated that these PMA capsules can be used for the encapsulation of DNA [23], [24], drug-containing oil-droplets [25] and peptides [26], and to eradicate colon cancer cells in vitro [25] and stimulate T-cells for vaccination [26]. Equally important as the choice of the individual building blocks is an understanding of the structural characteristics of the polymer carrier capsule containing liposomal cargo. In particular, the polymer membrane assembly and stability in physiological media, as well as the selective diffusion of biomolecules across the polymer membrane are key factors to be investigated.

Capsosome engineering can be achieved by individually addressing the challenges in each assembly step. In this study, we synthesize cholesterol-modified poly(l-lysine) (PLLc) and poly(methacrylic acid)-co-(cholesteryl methacrylate) (PMAc) (Scheme 1). We characterize suitable polymer precursor layers to maximize liposome adsorption depending on the charge and phase transition temperature of the liposomes and examine various capping layers to stably anchor liposomes to the surface and to enable the subsequent multilayer film assembly (Scheme 2). We provide details on the optimal film assembly conditions on planar surfaces and subsequently transfer the assembly of these films onto colloidal substrates to form the capsosomes. With the goal to control the properties and the function of the capsosomes, we present data on the structural integrity of the capsosomes, the cross-linking of the thiols in the film, the encapsulation efficiency of the enzymatic cargo within the polymer carrier capsules under various conditions, and the long-term stability of the capsosomes.

Section snippets

Materials

Poly(l-lysine) (PLL, 40,000–60,000 Da), poly(N-vinyl pyrrolidone) (PVP, 10,000 Da), methacrylic acid, 4-(2-hydroxyethyl)piperazine-1-ethane-sulfonic acid (HEPES), sodium chloride (NaCl), sodium acetate (NaOAc), chloroform, cholesterol, triethylamine (TEA, 99%), dichloromethane (DCM), hydroquinone, methacryloyl chloride, hydrochloric acid (HCl), sodium bicarbonate (NaHCO3), magnesium sulphate (MgSO4), methanol, 4-nitrophenol chloroformate (NPC, 95%), 2,2′-azoisobutyronitrile (AIBN), dioxane,

Results and discussion

To optimize and control the formation of (bio)degradable and selectively permeable capsosomes, we exploit a new approach of sandwiching liposomes between two polymer layers by using cholesterol as a non-covalent linker (Scheme 2). PLLc was synthesized by attaching cholesterol to the amines of the polymer via NPC, while controlled radical copolymerization via RAFT was chosen to synthesize cholesterol-modified PMA due to its monomer compatibility, good end-group purity, and control afforded over

Conclusions

We have demonstrated the successful synthesis of cholesterol-modified PLL and PMA, and that different types of liposomes can be stably anchored non-covalently to the polymer films by sandwiching them between a tailor-made PLLc precursor layer and a PMAc capping layer. Experiments on planar and colloidal substrates showed that PMASH/PVP multilayer films can be subsequently assembled on top of the anchored liposomes. We examined two approaches to achieve thiol-to-disulfide conversion with the use

Acknowledgements

This work was supported by the Australian Research Council under the Federation Fellowship and Discovery Project schemes and the Swiss National Science Foundation (SNF, PBEZB-118906). We thank Kerry Breheney for providing the β-lactamase.

References (45)

  • S. Kuiper et al.

    Enzymes containing porous polymersomes as nano reaction vessels for cascade reactions

    Org Biomol Chem

    (2008)
  • V.P. Torchilin

    Recent advances with liposomes as pharmaceutical carriers

    Nat Rev Drug Discov

    (2005)
  • T.N. Kropacheva et al.

    Enzymatic reaction in a vesicular microreactor: peptaibol-facilitated substrate transport

    Chem Biodivers

    (2007)
  • F. Caruso et al.

    Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating

    Science

    (1998)
  • E. Donath et al.

    Novel hollow polymer shells by colloid-templated assembly of polyelectrolytes

    Angew Chem Int Ed

    (1998)
  • G.B. Sukhorukov et al.

    Nanoengineered polymer capsules: tools for detection, controlled delivery, site-specific manipulation

    Small

    (2005)
  • D. Lensen et al.

    Polymeric microcapsules for synthetic applications

    Macromol Biosci

    (2008)
  • B.G. De Geest et al.

    Polyelectrolyte microcapsules for biomedical applications

    Soft Matter

    (2009)
  • B. Städler et al.

    Capsosomes: sub-compartmentalizing polyelectrolyte capsules using liposomes

    Langmuir

    (2009)
  • G. Decher et al.

    Buildup of ultrathin multilayer films by a self-assembly process: II. Consecutive adsorption of anionic and cationic bipolar amphiphiles and polyelectrolytes on charged surfaces

    Ber Bunsenges Phys Chem

    (1991)
  • G. Decher

    Fuzzy nanoassemblies: toward layered polymeric multicomposites

    Science

    (1997)
  • B. Städler et al.

    A micro-reactor with thousands of sub-compartments: enzyme-loaded liposomes within polymer capsules

    Angew Chem Int Ed

    (2009)
  • Cited by (100)

    • Multicompartment polymer capsules

      2022, Supramolecular Materials
    • Biocatalytic self-assembled synthetic vesicles and coacervates: From single compartment to artificial cells

      2022, Advances in Colloid and Interface Science
      Citation Excerpt :

      For example, Kataoka and coworkers developed injectable enzyme-loaded PICsomes (100 nm) as nanoreactors based on PEG-based block aniomers (PEG-b-PAsp), catiomers (Homo-P(Asp-AP)), and enzyme β-galactosidase (β-gal) or lysozyme for selective in vivo EPT to tumor cells [52]. Similarly, using alternate layers of polyelectrolytes and liposomes/ enzymes, e.g., GOx/PEI/CAT [63], GOx/CAT [64], PSS/PAH [65], PLLc/liposomes/PMAc/PVP/PMASH [66,67], PS-PIAT [43,45,58,59] layer-by-layer (LbL) capsules have been formed (Fig. 2B(c)). Such arrangement of polyelectrolyte provides sufficient movement of substrate and product across the capsule membrane, beneficial in enzyme nanoreactor development [104,137,138].

    • Enzyme-responsive polymer composites and their applications

      2020, Smart Polymer Nanocomposites: Biomedical and Environmental Applications
    • Enzymes as key features in therapeutic cell mimicry

      2017, Advanced Drug Delivery Reviews
    • Recent advances in compartmentalized synthetic architectures as drug carriers, cell mimics and artificial organelles

      2017, Colloids and Surfaces B: Biointerfaces
      Citation Excerpt :

      In particular, cholesterol-modified poly(L-Lysine), poly(methacrylic acid)-co-(cholesteryl methacrylate), poly(N-vinyl pyrrolidone)-block-(cholesteryl acrylate) and oleic acid-modified poly(methacrylic acid)-co-(oleyl methacrylate) have been successfully employed as precursor, separation and capping layers [84–88]. This strategy enabled for the incorporation of zwitterionic or negatively charged saturated or unsaturated liposomes without rupturing or displacement from polymer surfaces [84,86–88]. Non-degradable capsosomes have been assembled by employing the PSS and PAH polymer pair, since they afford structurally stable, non-aggregating capsules over an extended period of time [89].

    View all citing articles on Scopus
    View full text